The life sciences industry – pharmaceuticals, medical devices, diagnostics, vaccines and related businesses – is huge, growing and global, with international licensing, sales contracts, research and development agreements, and joint ventures.

Oradores:: James P. Duffy IV

Tipo de evento: Seminario

Nombre de la ubicación:
Charles River Associates, 200 Clarendon Street, Floor 9 , Boston MA
Fecha/hora de inicio:
10 April 2019
Fecha/hora de finalización:
10 April 2019

Each of these international ventures can lead to disputes, and well-positioned life sciences companies prefer international arbitration to litigation as the practical way to achieve confidential, widely enforceable judgments in a neutral setting.

Listen in as our distinguished panel of speakers explain why international arbitration is the preferred dispute resolution mechanism for life sciences disputes, before they take a deeper dive into some of the complex issues that can arise in such disputes.